Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100505715 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRKCI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BBIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130856 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MANEA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM139 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFT2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928615 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKACB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRGM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on